Financial decision-making in patients with neurodegenerative disorders - a pilot study. - Financial decision-making in patients with neurodegenerative disorders.

Rijksuniversiteit Groningen0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年6月18日

适应症

试验速览

暂无简介。

•Patients must be diagnosed with Alzheimer's Disease (AD), Mild Cognitive
•Impairment (MCI) or Parkinson's disease (PD) by an experienced neurologist
•according to published criteria:
•1. Patients with probable AD dementia according to the criteria of The National
•Institute on Aging and the Alzheimer*s Association (McKhann et al., 2011).
•1a. Only patients in the early stages of the disease (i.e. within two years
•after diagnosis) will be included, since in the later stages of disease the
•understanding of test instructions might be questioned.
•2. Patients with amnestic MCI (single and multi-domain) according to the
•criteria of The National Institute on Aging and the Alzheimer*s Association
•(Albert et al., 2011).
•3. Patients with idiopathic PD according to the UK Parkinson*s Disease Society
•Brain Bank Criteria (Hughes, Daniel, Kilford, & Lees, 1992).
•3a. Only patients in the early stages of the disease (i.e. within five years
•after diagnosis) will be included, since in the later stages of disease the
•understanding of test instructions might be questioned., In case of medication
•use, patients and healthy controls must be on a stable dosage of medication for
•at least one month.

发起方

Rijksuniversiteit Groningen